NCT07463079 Clinical Evaluation of a Soothing Moisturizing Lotion in Individuals With Atopic Eczema
| NCT ID | NCT07463079 |
| Status | Recruiting |
| Phase | — |
| Sponsor | USMARI Research & Innovation Centre |
| Condition | Eczema |
| Study Type | INTERVENTIONAL |
| Enrollment | 15 participants |
| Start Date | 2026-02-01 |
| Primary Completion | 2026-05-30 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 15 participants in total. It began in 2026-02-01 with a primary completion date of 2026-05-30.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
To investigate the safety and efficacy of the moisturizing lotion in improving eczema symptoms among individuals with atopic eczema in Malaysia. The study duration is 4 weeks and the skin assessment will be carried out at baseline and week 4. The main questions this study aims to answer are: 1. To investigate the safety of the moisturizing lotion for individuals with atopic eczema in Malaysia. 2. To determine the efficacy of the moisturizing lotion in improving eczema lesions among individuals with atopic eczema in Malaysia. 3. To assess the participants' satisfaction after using the moisturizing lotion.
Eligibility Criteria
Inclusion Criteria: * Healthy Malaysian women and men * Age above 18 years old * Clinically diagnosed with eczema with mild to moderate severity on any parts of the body as evaluated by Eczema Area and Severity Index (EASI) (score 10-20). Exclusion Criteria: * History of allergies or adverse reactions to moisturizers or components of the specific products being tested * History of chronic allergies * Pregnant, breastfeeding women, or those planning pregnancy during the study period * Participants with documented autoimmune diseases. * Currently undergoing or requiring active drug treatment for atopic dermatitis or eczema * Use of any medication (topical or systemic) that could interfere with the study aim (e.g. corticosteroids, calcineurin inhibitors, methotrexate) 3 months prior to the start of the study treatment and throughout the study * Current participation in another interventional clinical study * Presence of dermatological or systemic disorder other than eczema that could interfere with study outcomes
Frequently Asked Questions
Who can join the NCT07463079 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Eczema. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07463079 currently recruiting?
Yes, NCT07463079 is actively recruiting participants. Visit ClinicalTrials.gov or contact USMARI Research & Innovation Centre to inquire about joining.
Where is the NCT07463079 trial being conducted?
This trial is being conducted at Petaling Jaya, Malaysia.
Who is sponsoring the NCT07463079 clinical trial?
NCT07463079 is sponsored by USMARI Research & Innovation Centre. The trial plans to enroll 15 participants.
Related Trials
Related Intelligence Guides
In-depth guides covering this condition's trials, eligibility, and what to expect.